Home » Reports » Broker Ratings » GlaxoSmithKline plc 10.5% Potential Upside Indicated by Deutsche Bank
broker ratings

GlaxoSmithKline plc 10.5% Potential Upside Indicated by Deutsche Bank

GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) had its stock rating noted as ‘Retains’ with the recommendation being set at ‘HOLD’ this morning by analysts at Deutsche Bank. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set their target price at 1610 GBX on its stock. This would imply the analyst believes there is now a potential upside of 10.5% from the opening price of 1457.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 46.5 points and decreased 262.5 points respectively. The 1 year high share price is 1745.56 GBX while the year low share price is currently 1444 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,534.08 GBX and a 200 Day Moving Average share price is recorded at 1,607.92. There are currently 4,918,522,008 shares in issue with the average daily volume traded being 6,083,193. Market capitalisation for LON:GSK is £72,056,347,417 GBP.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!